Lhermitte-Duclos disease

2001-10-01   Michel Longy  

Unite de Genetique Oncologique, Institut Bergonie, 180, rue de Saint-Genes, 33076 Bordeaux, France

Identity

Name

Lhermitte-Duclos disease

Alias

Dysplastic gangliocytoma of the cerebellum

Note

Lhermitte-Duclos disease may either be considered as a Cancer Prone disease (herein described) with an autosomal dominant inheritance mode or as a Solid Tumor on itself (see Dysplastic gangliocytoma of the cerebellum).

Inheritance

Sporadic, or autosomal dominant if associated with Cowden disease

Omim

158350

Mesh

D006223

Orphanet

65285 Lhermitte-Duclos disease

Umls

C0391826;C1266181

Clinics

Phenotype and clinics

  • Lhermitte-Duclos disease consists in the occurrence of a slowly enlarging mass within the cerebellar cortex corresponding histologically to a cerebellar hamartoma.
  • Clinical manifestations are commonly a long standing history of vague defined neurological symptoms related to raised intracanial pressure and cerebellar signs affecting usually a young adult.
  • Diagnosis is based on cerebral imaging methods, mainly NMR-imaging.
  • Therapy consists of decompression of the posterior fossa by total surgical removal of the tumour mass.
  • Histopathological finding confirm the diagnosis of dysplastic gangliocytoma of the cerebellum in front of a hamartoma lesion with widening of the molecular layer occupied by abnormal ganglion cells, absence of Purkinje cell layer and hypertrophy of granular layer.
  • Related syndromes: Association with other lesions such as macrocephaly, polydactylia, multiple hemangioma, goiter, intestinal polyps was often observed. One case of familial cluster was reported. In fact, many cases of dysplastic cerebellar gangliocytoma are related to Cowden disease and such patients show various finding of this autosomal dominant condition with variable expression.

    • Neoplastic risk

    In cases of Lhermitte-Duclos related to a Cowden disease, malignant tumours characterizing this affection (mainly breast carcinoma and thyroid carcinoma) can occur.

    Genes involved and Proteins

    Expression

    403 amino-acids, phosphatase with tumor suppressive effects, negative regulator of the PI3K\/Akt signal cell pathway by dephosphorylating PIP3

    Article Bibliography

    Pubmed IDLast YearTitleAuthors
    5345120Not available in PubMed
    11516554Not available in PubMed
    1859181Not available in PubMed

    Citation

    Michel Longy

    Lhermitte-Duclos disease

    Atlas Genet Cytogenet Oncol Haematol. 2001-10-01

    Online version: http://atlasgeneticsoncology.org/cancer-prone-disease/10065/lhermitte-duclos-disease